Like other drugmakers, Glaxo is encountering declining earnings. The drugmaker faces increasing competition with generics, setbacks to products and fewer potential future drugs in production.
By Jane Wardell, AP Business Writer
Full Story: http://www.usatoday.com/money/companies/management/2008-06-11-glaxo-rd-cuts_N.htm